Evolutionary Genomics, Inc. Payments to Acquire Equity Method Investments
Evolutionary Genomics, Inc. reported Payments to Acquire Equity Method Investments of $249.28 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2016-02-19.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2016-02-19
- Evolutionary Genomics, Inc. payments to acquire equity method investments for fiscal 2014 was $249.28K.
| Period end | Payments to Acquire Equity Method Investments 12 month |
|---|---|
| 2014-12-31 | $249.28K 10-K · filed 2016-02-19 |